Perennial Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-08-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental ANDA from Lannett Company to market a generic montelukast sodium product. Montelukast is used in the managem…
-
FDA approval · 2013-08-14FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast sodium from Torrent Pharmaceuticals Limited, formalizing approval of this generic mo…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis [Phase 3]
This is a Phase 3 open-label trial of GW685698X in pediatric patients with perennial allergic rhinitis. Results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis [Phase 2]
Phase 2 trial evaluating an immunomodulatory therapy in adults with perennial allergic rhinitis and house dust mite allergy; results were po…
-
FDA approval · 2013-06-26FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Montelukast by Sandoz Inc., indicating approval of a change to this generic Montelukast product.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Perennial Allergic Rhinitis In Pediatric Subjects [Phase 3]
A Phase 3 trial evaluating a treatment for perennial allergic rhinitis in pediatric subjects has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis [Phase 3]
Phase 3 placebo-controlled study of GW685698X in pediatric perennial allergic rhinitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-04-30Clinical Trial Update: Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray [Phase 3]
Phase 3 trial comparing a nasal aerosol to an aqueous nasal spray in perennial allergic rhinitis, with results posted.
-
FDA approval · 2013-04-29FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for Montelukast Sodium (ANDA 202717). This action confirms approval of a supp…
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of concomitant montelukast sodium and levocetirizine dihydrochloride in perennial allergic …
-
FDA approval · 2013-03-26FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) filed by Viatris Specialty LLC…
-
FDA approval · 2013-02-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental abbreviated new drug application for Montelukast Sodium from Dr. Reddy's Laboratories Limited, expanding generic…
-
FDA approval · 2013-01-31FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc. for montelukast, granting approval of changes to the generic montelukast product un…
-
FDA approval · 2012-12-17FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Montelukast Sodium by Accord Healthcare Inc., resulting in an approved modification to the produ…
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis [Phase 3]
Phase 3 trial update evaluating a novel questionnaire to assess patient satisfaction and preference for intranasal corticosteroids in perenn…
-
FDA approval · 2012-10-18FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2012-10-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for montelukast sodium from Torrent Pharmaceuticals Limited, enabling the generic product to be mark…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: The Efficacy & Safety of the UAS Immunotherapy Protocol
The trial has completed evaluating the efficacy and safety of the UAS Immunotherapy Protocol for perennial allergic rhinitis with seasonal v…
-
FDA approval · 2012-09-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension [Phase 3]
Phase 3 clinical trial evaluating a symptomatic treatment for perennial allergic rhinitis has completed, including a one-year safety extensi…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber [Phase 4]
Phase 4 randomized, double-blind, placebo-controlled, four-period crossover study evaluating the dose-response of fluticasone propionate in …
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis [Phase 4]
Phase 4 safety trial update for PATANASE nasal spray in perennial allergic rhinitis has completed with results posted.
-
FDA approval · 2012-08-23FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine HCl and pseudoephedrine HCl). The submission was …
-
FDA approval · 2012-08-10FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) submitted by Viatris Specialty LLC…
-
FDA approval · 2012-08-06FDA Approved: MONTELUKAST SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approves the original ANDA for Montelukast sodium from Dr. Reddy's Laboratories Limited, establishing a generic Montelukast sodium produ…